Multijunction silicon nanowire particles that generate over 10 volts under solar or near-infrared illumination, enabling water disinfection through reactive oxygen species production and direct microbial cell or viral capsid disruption.
This solution leverages engineered silicon nanowire particles containing multiple p-n junctions that produce more than 10 volts of photovoltage under visible and near-infrared illumination. When suspended in water and exposed to light, these particles generate powerful oxidizing and reducing potentials capable of producing reactive oxygen species and directly disrupting microbial cell membranes or virus capsids. The technology offers a light-activated, chemical-free approach to disinfection with potential applications in water treatment, surface sanitization, and pathogen control.
Key features:
How it works:
The engineered p-n junctions within each silicon nanowire create internal voltage amplification under illumination. When photons are absorbed, the resulting photovoltage drives electrochemical reactions at the particle surface, generating reactive oxygen species such as hydroxyl radicals and singlet oxygen. Simultaneously, the high oxidative and reductive potentials can directly compromise the structural integrity of bacterial membranes and viral capsids, leading to pathogen inactivation.
The particles have been synthesized and electrically characterized, confirming their ability to produce high voltages under visible and near-infrared light. They have also been suspended in water and demonstrated photoelectrochemical activity. However, the technology has not yet been tested in a microbial environment, and disinfectant efficacy remains to be validated. Current readiness is at the laboratory validation stage, with initial work focused on confirming reactive oxygen species production and subsequent testing against microbial targets. The research team is actively seeking collaboration on microbial testing protocols and evaluation methodologies to advance toward practical disinfection applications.
UNC–Chapel Hill is a comprehensive public research university and the state’s flagship, pairing broad academic depth with a major academic health system. Industry partners access co‑located core facilities, sponsored research, and an on‑campus innovation hub that connects companies to faculty and advanced instrumentation. Integration with a major hospital system and statewide clinics enables patient access, clinical trials, and real‑world evidence collaborations. Minutes from Research Triangle Park, the university works within a dense corporate R&D ecosystem. Research is supported by strong competitive federal funding, including NIH and NSF, and a dedicated technology transfer office streamlines IP, licensing, MTAs, and startup formation.